knowledge -WSS

knowledge

author：knowledge 2025-08-26 10:53:15 - browse：6

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Medicare drug price negotiation hearing pits pharma v Biden admin

WSS

Dana Farber says 6 studies to be retracted and 31 corrected

The public health thinking behind the CDC’s new Covid guidance

HPV vaccine, cervical cancer study delivers historic results

Flu vaccine reformulation won't be easy, manufacturers warn

Maisha Meds is a PBM, but don't call it that

Pumping milk in bathrooms at health conferences is common

focus

knowledge

hotspot

Apple is now the first public company to be valued at $3 trillion

Medicare bonuses could stop drug shortages under Senate plan

Sports medicine is finally prioritizing gender equality

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

United colonoscopy coverage change 'may cost lives,' doctors say

Future doctors need a strong humanities education

How to save PrEP access — and even expand it

The public health thinking behind the CDC’s new Covid guidance

Sports medicine is finally prioritizing gender equality

The inclusion problem at the heart of rehabilitation research

hotspot

Medicare drug price negotiation continues, as pharma counteroffers

Mass General, Mayo Clinic look to monetize custom

Head of FDA's diagnostics center, who led through Covid, retires

Cardiologists urge adding sexual orientation, gender identity to health records

Medicare bonuses could stop drug shortages under Senate plan

A pediatrician calls for Congress to pass the child tax credit deal

Wikipedia

Wikipedia

entertainment

focus